Skip to main content

Table 2 CUP subsets and outcome.

From: Angiogenesis in cancer of unknown primary: clinicopathological study of CD34, VEGF and TSP-1

Subgroups

(#)

(%)

   Favorable

50

62

   Unfavorable

31

38

Treatment

(#)

(%)

   Chemotherapy

64

78

   Radiotherapy

4

6

Median survival

(months)

 

   All cases

10.5

 

   favourable cases

11.5

 

   unfavorable cases

8.5